Utah Medical Products (UTMD) Competitors $54.95 -0.65 (-1.17%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$54.94 -0.02 (-0.03%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTMD vs. CERS, OSUR, ANIK, WST, COO, ALGN, MMSI, HAE, ICUI, and XRAYShould you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Utah Medical Products vs. Its Competitors Cerus OraSure Technologies Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA Utah Medical Products (NASDAQ:UTMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk. Which has more volatility & risk, UTMD or CERS? Utah Medical Products has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Do analysts recommend UTMD or CERS? Cerus has a consensus target price of $3.50, indicating a potential upside of 175.59%. Given Cerus' stronger consensus rating and higher probable upside, analysts clearly believe Cerus is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, UTMD or CERS? Utah Medical Products has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUtah Medical Products$40.90M4.37$13.87M$3.7414.69Cerus$185.14M1.31-$20.92M-$0.10-12.70 Does the media refer more to UTMD or CERS? In the previous week, Utah Medical Products had 3 more articles in the media than Cerus. MarketBeat recorded 5 mentions for Utah Medical Products and 2 mentions for Cerus. Cerus' average media sentiment score of 0.88 beat Utah Medical Products' score of 0.49 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Utah Medical Products 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cerus 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is UTMD or CERS more profitable? Utah Medical Products has a net margin of 32.34% compared to Cerus' net margin of -10.23%. Utah Medical Products' return on equity of 10.50% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Utah Medical Products32.34% 10.50% 10.05% Cerus -10.23%-34.81%-9.68% Do insiders and institutionals believe in UTMD or CERS? 69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 7.4% of Utah Medical Products shares are owned by company insiders. Comparatively, 5.6% of Cerus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryUtah Medical Products beats Cerus on 9 of the 16 factors compared between the two stocks. Get Utah Medical Products News Delivered to You Automatically Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTMD vs. The Competition Export to ExcelMetricUtah Medical ProductsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$180.60M$10.40B$5.48B$9.51BDividend Yield2.19%1.99%4.73%4.09%P/E Ratio14.6918.4228.6723.80Price / Sales4.3729.01373.9066.58Price / Cash11.2822.3135.4557.96Price / Book1.593.478.275.55Net Income$13.87M$234.77M$3.24B$259.03M7 Day Performance-6.13%-4.82%-3.69%-4.59%1 Month Performance-4.42%1.80%4.33%4.46%1 Year Performance-18.54%-12.51%25.95%18.03% Utah Medical Products Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTMDUtah Medical Products2.9773 of 5 stars$54.95-1.2%N/A-19.4%$180.60M$40.90M14.69180News CoverageDividend AnnouncementCERSCerus3.1813 of 5 stars$1.36-2.2%$3.50+157.4%-37.7%$265.71M$180.27M-13.60290Upcoming EarningsOSUROraSure Technologies2.1938 of 5 stars$3.35-0.3%$3.00-10.4%-33.3%$251.33M$161.63M-7.98840Upcoming EarningsANIKAnika Therapeutics4.4102 of 5 stars$11.33-1.5%$20.00+76.5%-67.1%$164.93M$119.91M-2.92300News CoverageAnalyst ForecastWSTWest Pharmaceutical Services4.6138 of 5 stars$257.36-2.3%$320.71+24.6%-20.9%$18.93B$2.89B38.5310,600Short Interest ↑COOCooper Companies3.2509 of 5 stars$72.91-2.3%$96.73+32.7%-24.8%$14.92B$3.99B35.3916,000ALGNAlign Technology4.9446 of 5 stars$207.19+0.8%$242.92+17.2%-40.2%$14.90B$3.98B37.7420,945Trending NewsEarnings ReportAnalyst ForecastInsider TradeMMSIMerit Medical Systems4.5585 of 5 stars$84.46-0.3%$109.11+29.2%+0.8%$5.01B$1.36B41.407,400Trending NewsEarnings ReportAnalyst ForecastHAEHaemonetics4.8133 of 5 stars$74.66-0.7%$97.30+30.3%-17.2%$3.61B$1.36B22.563,023News CoveragePositive NewsUpcoming EarningsICUIICU Medical4.6059 of 5 stars$127.50-1.8%$192.67+51.1%+0.9%$3.20B$2.38B-33.2915,000News CoveragePositive NewsUpcoming EarningsXRAYDENTSPLY SIRONA4.5904 of 5 stars$16.07+0.2%$19.60+22.0%-46.5%$3.19B$3.79B-3.5414,000Positive NewsUpcoming Earnings Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTMD) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Utah Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Utah Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
